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ABSTRACT
In eukaryotes splicing of pre-mRNAs is mediated by the
spliceosome, a dynamic complex of small nuclear
ribonucleoprotein particles (snRNPs) that associate
transiently during spliceosome assembly and the
splicing reaction. We have purified snRNPs from
nuclear extracts of Drosophila cells by affinity
chromatography with an antibody specific for the
trimethylguanosine (m3G) cap structure of snRNAs
U1-U5. The polypeptide components of Drosophila
snRNPs have been characterized and shown to consist
of a number of proteins shared by all the snRNPs, and
some proteins which appear to be specific to individual
snRNP particles. On the basis of their apparent
molecular weight and antigenicity many of these
common and particle specific Drosophila snRNP
proteins are remarkably conserved between Drosophila
and human spliceosomes. By probing western blots of
the Drosophila snRNP polypeptides with a number of
antisera raised against human snRNP proteins,
Drosophila polypeptides equivalent to many of the
HeLa snRNP-common proteins have been identified, as
well as candidates for a number of Ul, U2 and
U5-specific proteins.
INTRODUCTION
In eukaryotes the excision of intervening sequences from pre-
mRNA is catalyzed in a large ribonucleoprotein complex, the
spliceosome. The spliceosome is composed of at least 30 distinct
proteins and the five major small nuclear RNA (snRNA)
molecules U1, U2, U4, U5 and U6. The U snRNAs can be
recovered from nuclear extracts as four individual small nuclear
ribonucleoprotein (snRNP) complexes, the monomeric Ul, U2
and U5 snRNP particles and the dimeric U4/U6 snRNP in which
the U4 and U6 snRNAs are found base paired (1,2).
The protein composition of the snRNP complexes has been
studied in detail in human and rodent nuclear extracts (3,4). Eight
distinct polypeptides, B, B', D1, D2, D3, E, F and G, with
apparent molecular weights of between 9 and 29 (MrX 10-3),
are common to all four snRNPs and form a common snRNP core.
In addition, individual snRNPs have been shown to contain
characteristic particle-specific proteins, denoted 70K, A and C
for Ul; A' and B" for U2; and 15, 40, 52, 100, 102, 116 and
200K for U5. The U5 snRNP has a particularly complex protein
composition and sediments through glycerol gradients more
rapidly than the other snRNPs (5). An even larger tripartite
U41U5/U6 complex can be isolated under low salt conditions and
contains at least four further polypeptides (4,6-8).
Antisera from patients with a variety of connective tissue
diseases recognize many of the snRNP polypeptides. Anti-RNP
autoantibodies, from patients with mixed connective tissue disease
(MCTD), react with the Ul-specific proteins A, C, and 70K.
Anti-Sm sera from patients with systemic lupus erythematosus
(SLE) immunoreact with the core (Sm) proteins B', B and D
(9,10), with variable reactivity to DI, D2 and D3 (1 1), and less
frequently with E, F and G (12). These sera have been used to
study the composition of snRNPs from a variety of species by
immunoprecipitation and immunoblotting. These studies indicate
that the protein composition of snRNPs is remarkably conserved
throughout eukaryotes (reviewed 3) as indeed are the sequences
of the U snRNAs (reviewed 13).
Purification of snRNPs has been facilitated by the use of the
human autoantibodies, but more successfully by the use of mono
and polyclonal antisera raised against modified nucleosides
peculiar to the snRNAs. In particular antibodies which recognize
the highly methylated nucleoside 2,2,7-trimethylguanosine
(m3G), which is found as a 5'-cap on U1, U2, U4 and U5
snRNAs, allow a single step purification of m3G-capped
snRNPs from nuclear extracts by immunoaffinity
chromatography. Native snRNPs can be recovered by desorption
with an excess of m3G (or the cross-reactive nucleoside
7-methylguanosine, m7G) or by elution with salt (14-17).
The Drosophila U snRNAs closely resemble those of
vertebrates in size, structure and nucleotide sequence (18,
reviewed 13). Anti-Sm and anti-RNP antisera have identified a
number of low molecular weight potential snRNP polypeptides
(19,20). In this study we have used a monoclonal antibody which
recognizes the 5'-nucleotide cap of snRNAs (16) to
immunoaffinity purify snRNPs from nuclear extracts of
Drosophila cells in order to identify their protein components
and to compare them to those of HeLa cells.
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MATERIALS AND METHODS
Cell growth and preparation of nuclear extracts
The Drosophila melanogaster Schneider 2 cell line was
propagated at 22°C in suspension in Schneider's (modified)
Drosophila Medium (purchased from Imperial Laboratories, UK)
supplemented with 5% foetal calf serum, 100U/ml penicillin and
100izg/ml streptomycin. Nuclear extracts were prepared by the
method of Dignam et al., (21) without homogenization of cells
and with the addition of 0.5% v/v NP40 to disrupt the cytoplasmic
membrane. HeLa cell nuclear extracts and purified snRNPs were
kindly provided by Silke Borner.
Anti-m3G immunoaffinity chromatography of snRNPs
Affinity purification of m3G-capped snRNPs from nuclear
extracts was performed by using mAb H-20 bound covalently
to CNBr-activated Sepharose 4B essentially as described (16).
Nuclear extract prepared as above was passed over a 5ml
H-20-Sepharose column and bound RNA-protein complexes were





Fig. 1. Immunoaffinity purification of Prosophila snRNPs. Analysis of fractions
upon chromatography over H-20-Sepharose. (A) Coomassie stained proteins
resolved on a 15% polyacrylamide/SDS gel compared with HeLa snRNP proteins
(H) and size markers (S) (Mr X 10-3). L, nuclear extract loaded onto column;
F, unbound flow through; W, initial wash after loading; E, eluate desorbed on
addition of m7G; U, proteins in 6M urea wash to regenerate column. (B)
Ethidium bromide stained RNA resolved on a 6% polyacrylamide/urea gel.
Fractions as above except that W, wash fraction was sampled after extensive
washing of the column prior to desorption. The identities of U 1, 4, 5 and 6 RNAs
were determined by hybridizing a northern blot of the gel with unique
oligonucleotide probes. Positions of 5S rRNA and 4S tRNA are indicated.
Anti-sera
Rabbit: anti-FP8.1 raised against a portion of yeast U5 snRNP
specific protein PRP8 fused to ,B-galactosidase and affinity-
purified against the same portion of PRP8 fused to the trpE
protein (22).
Monoclonal antibodies: Y12 anti-Sm type (9); 7.13 anti-HeLa
Dl (23); H-20 anti-m3G (16); 4G3 anti-HeLa U2B' (24); HIll
anti-HeLa Ul 70K, H304 anti-HeLa Ul A and H386 anti-HeLa
Ul 70K and U5 lOOK (8,25).
Patient 7, E74 and Plasma D anti-Sm sera from patients with
systemic lupus erythematosus were kindly provided by Prof.
H.Peter, Freiburg.
Alkaline phosphatase-conjugated secondary antibodies (against
rabbit, human or mouse IgG or mouse IgM antibodies) were
purchased from Promega and Bio-Rad.
RNA and protein analysis
Samples were extracted with 1 volume of PCA (phenol,
chloroform, isoamylalcohol 50:50:1) with 0.5% (w/v) SDS.
Following phase separation by centrifugation RNAs were
recovered from the aqueous phase by ethanol precipitation.
Proteins were precipitated from the organic phase with S volumes
of acetone.
RNAs were fractionated by electrophoresis through 10%
polyacrylamide gels containing 7M urea, 10mM Tris-Borate
pH8.2 and 2mM EDTA (TBE). RNA was visualized by staining
with ethidium bromide (0.5,ug/ml) or with silver (26). RNA was
transferred to nylon membrane (Amersham) by electrophoresis
in 0.5xTBE for 3h at 45V and fixed by UV irradiation. U
snRNA-specific oligonucleotides were 5'-end labelled using
polynucleotide kinase and hybridized to pre-blocked filters in
6 x SSC (3M NaCl, 3M trisodium citrate), 5 x Denhardt's
solution, 100ytg/ml denatured salmon sperm DNA for 2h at 4°C
and washed briefly in 6 x SSC at 20'C before autoradiography.
Oligonucleotides were synthesized by OSWEL DNA Service,
Edinburgh University, and were directed against: Drosophila US
Fig. 2. Comparison of Drosophila (D) with HeLa (H) snRNP proteins resolved
on a 12% acrylamide/SDS gel polymerized in the presence of high TEMED
concentration (see Methods). The migration of size standards is shown (14-205





Nucleic Acids Research, Vol. 19, No. 21 5879
bases 68-83 GACTCTTAGAGTGTTC; Human U4 bases
58-75 GGAAAAG'ITl'l'lCAATrAG; Human U6 bases 78-95
GGCTTCACGAATTTGCGT.
Proteins were fractionated by SDS-gel electrophoresis (27).
In order to resolve small proteins, in particular the HeLa D
proteins, gels were polymerized where noted in the presence of
high TEMED concentrations (0.04% compared to 0.01%, ref.
11). Protein bands were detected by staining with Coomassie
brilliant blue G250 or were transferred to nitrocellulose by
electrophoresis overnight at 25V in 25mM Tris, 19mM glycine
(28). Blots were then probed with sera or monoclonal antibodies
as described previously (25) and antibodies detected with aLkaline-
phosphatase-conjugated secondary antibodies and chromogenic
substrates (Promega).
Glycerol gradient centrifugation
Affinity purified snRNP fraction (200tg protein, prepared as
described above) was layered onto a linear 10-30% (v/v)
glycerol gradient in a buffer containing 20mM Hepes-KOH pH8,
150mM KCI, 1.5mM MgCl2, 0.5mM PMSF, 0.5mM DTT,
and 2,Ag of leupeptin per ml. The gradient was centrifuged in
a Beckman SW40 rotor at 29 krpm for 18h. 500,u fractions were
collected and PCA extracted for analysis as described above.
RESULTS
Purification of Drosophda snRNPs from nuclear extracts by
chromatography on H-20 affinity columns
Nuclear extract prepared from 0.5 x 1010 Drosophila cells was
purified by H-20 immunoaffinity chromatography (Materials and
Methods) and yielded 620yg of protein upon desorption of bound
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routinely achieved with HeLa cell extracts. Analysis of the RNA
eluted from the H-20 column revealed a marked enrichment of
the U snRNAs from the nuclear extracts (Figure iB).
Characterization of Drosophila snRNP proteins in relationship
to their human counterparts
The protein component of purified Drosophila snRNPs was
analysed by SDS-gel electrophoresis and compared with purified
snRNPs from HeLa cells. A larger number of individual proteins
were enriched from Drosophila in comparison with HeLa cells
from which around 30 major proteins were selectively enriched
(Figures lA, 2). As a consequence, few direct correlations
between the sizes of Drosophila and human proteins are
immediately apparent.
Drosophila and HeLa snRNP proteins were transferred to
nitrocellulose after gel electrophoresis and probed with a variety
of antisera reactive to HeLa snRNP proteins in order to investigate
the relationship between the affinity purified Drosophila and
human proteins. When strips were probed with anti-Sm sera from
three human SLE patients a number of Drosophila Sm proteins
were identified (Figure 3A). On the basis of their apparent
molecular weight these may include at least two D proteins, Du
and DL (DL may in fact be a doublet, see lane 4 and also
Figure 2A), at least one potential B protein, a potential A protein,
several proteins with similar mobility to the HeLa U 1 70K protein
and a doublet at about 100K Oane 4). The exact relationship of
Du and DL to the HeLa Dl, 2 and 3 proteins is not clear but
E 74 serum, which recognizes human Dl and D3, only
recognizes the more slowly migrating Drosophila protein Du
(lane 1) whilst sera recognizing all three HeLa D proteins also
recognize DL (lanes 2 and 4).
Various monoclonal antibodies and rabbit antisera which react
with specific snRNP proteins were also used as probes
Bi 2 3 4 5 6 7














Fig. 3. Immunological comparison of Drosophila (D) with HeLa (H) snRNP proteins. (A) Nitrocellulose strips of electroblotted snRNP proteins probed with various
human anti-Sm antisera. 1, E 74; 2, Plasma D; 3, Patient 7 (1:200 dilution); 4, Patient 7 (1:50 dilution). (B) Strips probed with various monospecific rabbit and
mouse antibodies: 1, Y12; 2, 7.13; 3, HIll; 4, H386; 5, H304; 6, anti-FP8.1; 7, 4G3.
...:*
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(Figure 3B). These antibodies confirmed the existence of at least
two distinct D proteins Du and DL (lanes 1 and 2). Again the
relationship of Du and DL to D1, D2 and D3 could not be
unambiguously assigned since in this case antibodies raised
against Dl (7.13) recognized DL (lane 2). The mobility of the
D proteins was clearly affected by the composition of the
acrylamide gel used (Materials and Methods, 11). In a 12%
acrylamide gel polymerized with high concentrations ofTEMED,
Du and DL ran with similar mobility to HeLa D proteins
(Figure 3A lanes 1,2; Figure 3B lanes 1,2), but in a 14%
Table 1. Comparison of human and Drosophila snRNP polypeptides
HELA snRNP Proteins Equivalent Drosophila proteins




B' 29 Bu 28
B 28 BL 27
D3 18 Du 18.5
D2 16.5 DL 17 may be doublet
DI 16
E 12 E 12.5
F 11 F 11
G 9 G 9
Ul snRNP proteins
70K 70(62) 70K 56 oders of 54 & 61?
A 34 A 38
C 22 C 14.5
U2 snRNP proteins
B' 28.5 B" 28
U5 snRNP proteins
200(+)K >200 200K/PRP8 240
116K 116 120K 120
102K 102 105K 105 may be doublet
1OOK 100
52K 52 54K 54
40K 40 42K 42
(a) From Luhrmann et al.,(4). (b) MrX I0-.
acrylamide, low TEMED gel the Drosophila D proteins migrated
more slowly than the HeLa counterparts (Figure 3A lanes 3,4).
As was observed with the Human Sm antisera only a single
Drosophila B protein was detected by the anti-Sm monoclonal
antibody Y12 (lane 1). The antibodies H 111 and H386 (lanes
3,4) define a unique Drosophila band related to the HeLa U 1
70K protein whereas the human anti-Sm sera (Figure 3A)
indicated that there may be multiple post-translationally modified
variants of this protein as has been observed in HeLa cells.
Antiserum raised against a portion of the yeast U5 snRNP specific
protein PRP8 (22) recognized large 200-260kDa proteins in both
HeLa and Drosophila snRNPs (lane 6) as previously reported
(29-31). Antisera raised against other regions of the yeast protein
(22) also recognized both the HeLa and Drosophila protein (30,
results not shown). A monoclonal (4G3) raised against the HeLa
U2-specific B' protein (24) recognized a similarly sized
Drosophila protein (lane 7).
A monoclonal antibody specific to the HeLa A protein (H304,
lane 5) and rabbit antipeptide antisera to the HeLa C and G
proteins (results not shown) failed to recognize equivalent
Drosophila proteins, perhaps reflecting lack of conservation of
these epitopes between Drosophila and humans. Results from
these and the later analyses are summarized in Table 1.
Resolution of the Drosophila U5 snRNP particle by
sedimentation through glycerol gradients
The immunoaffinity purified Drosophila snRNP fraction was
subjected to sedimentation analysis in a linear 10-30% (v/v)
glycerol gradient in order to investigate whether rapidly and
slowly sedimenting particles could be resolved as has been
demonstrated for HeLa snRNP particles (5). When the protein
content of the glycerol gradient fractions was analysed by gel
electrophoresis a pattern remarkably similar to that observed with
HeLa extracts was found (Figure 4A). The snRNP particles
appear to have sedimented in two different size ranges; the rapidly
sedimenting particles (fractions 14- 17) appear to correspond to
the 20S US snRNPs of HeLa (5) whilst the more slowly
sedimenting particles (fractions 4-10) resemble in composition
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Fig. 4. Sedimentation of Drosophila snRNP particles in a linear 10-30% glycerol gradient. (A) Protein fractions 1 (top) to 27 (bottom of gradient) resolved on
a 12% acrylamide/SDS gel polymerized in the presence of high TEMED concentration. L, sample of snRNP fraction loaded onto gradient. (B) RNA prepared from
glycerol gradient fractions resolved on a 6% acrylamide/urea gel, transferred to nylon membrane and independently probed with U 1, 5 and 6 specific oligonucleotide
probes. (C) Composition of rapidly sedimenting particles (fractions 14-17) compared to slowly sedimenting particles (fractions 4- 10) and total HeLa (H) and Drosophila
(L) snRNP proteins. The major HeLa proteins are indicated (G-200) and proteins discussed in the text are highlighted.
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the smaller snRNPs, including the Ul snRNP, with a value of
around lOS.
When the RNA present in the gradient fractions was analysed
by urea/acrylamide electrophoresis and northern blot a less
distinct pattern of separation was found. Whilst a peak of U5
snRNA indeed co-sedimented with the 20S particles (fractions
14 and 16, Figure 4B) all of the U snRNAs examined appeared
to smear throughout the gradient, perhaps due to the loss of
proteins from the snRNPs. However, the Ul and U6 snRNAs
were more concentrated further up the gradient than U5 (fractions
6-12, Figure 4B). The protein composition of the two resolved
particle types is shown in greater detail in Figure 4C. Common
core proteins present in both particle types include two candidate
B proteins, with apparent molecular weights marginally smaller
than HeLa B and B' (the faster migrating species, BL,
corresponds to the B protein recognized by anti-Sm sera;
Figure 3A lanes 1,2 and 4); the two D proteins Du and DL
identified immunologically above, and two proteins with similar
sizes to the HeLa core proteins E and F. Whilst a protein of
similar size to Hela G is present in the total Drosophila snRNP
fraction (arrowed in lane L), this band is not discernible in either
of the glycerol gradient fractions.
The more slowly migrating complexes (fractions 4-10) appear
to contain the Ul snRNP specific proteins A and 70K. Again
a number of proteins with apparent size of about 70 000 can be
distinguished, perhaps indicating that multiple post-translationally
modified variants of this protein are found in Drosophila as in
HeLa. Alternatively this protein could have suffered proteolytic
degradation during purification. Of the three candidate 70K
proteins in Drosophila with Mr 54 000, 56 000 and 61 000 it
appears to be the 56 000 species which is recognized by the
anti-70K monoclonal antibodies. Whilst there is no protein of
similar molecular weight to the HeLa C protein (Mr 22 000) a
prominent polypeptide of Mr 14 500 may be the equivalent
Drosophila protein. The Drosophila equivalent of the U2-specific
protein B' (Mr 28 000) was shown to be present in this fraction
by western blotting and probing with the antibody 4G3 (result
not shown). The Drosophila B' protein identified by western blot
comigrates with the larger of the two candidate B proteins, BU,
which is present in both fractions of snRNPs in Figure 4C.
The rapidly sedimenting particles in fractions 14- 17 resemble
HeLa U5 snRNPs in protein composition. The high molecular
weight 240-260K protein which is recognized by antibodies
raised against the yeast U5-specific protein PRP8 is present, as
are at least two proteins of Mr 105-120 000 which might
correspond to the 100, 102 and 116K proteins in HeLa. Two
proteins of similar size to the HeLa 40K and 52K proteins also
co-sediment with these Drosophila US snRNP particles.
Probing western blots of these glycerol gradient fractions with
the human anti-Sm antisera confirmed the presence of the
common proteins BL, Du and DL in both fractions 4-10 and
14- 17, whilst the Drosophila equivalents of the Ul-specific 70K
and A, and U2-specific B' proteins where restricted to fractions
4-10, and the U5-specific 100 and 200K proteins to fractions
14-17 (results not shown).
DISCUSSION
D. melanogaster provides an ideal model higher eukaryote in
which to study the mechanism and regulation of pre-mRNA
splicing. An increasing number of genes have been described
where splicing of their transcripts is regulated in a developmental,
sex or tissue-specific manner (see references 32-37 for
examples) and a number of genes that regulate splicing have been
identified, several of which encode proteins with RNA binding
motifs resembling those found in mammalian snRNP proteins
(38-41). Furthermore, nuclear extracts prepared from embryos
or cultured Drosophila cells have been shown to accurately splice
mRNA precursors by a similar mechanism to that observed in
yeast and mammals (42).
In order to characterize the Drosophila splicing machinery we
have purified snRNP particles from cultured Drosophila cell
extracts by immunoaffinity chromatography and analysed their
protein composition. The polypeptide components ofDrosophila
snRNPs appear remarkably similar to those characterized in HeLa
cells. On the basis of molecular weight, antigenicity and particle
density-sedimentation we have identified Drosophila proteins
corresponding to most of the characterized HeLa polypeptides
(summarized in Table 1).
Eight proteins have been identified in HeLa extracts which are
common to all snRNP particles: B, B', Dl, D2, D3, E, F and
G. On the basis of molecular weight Drosophila has proteins
corresponding to most if not all of these, and at least three proteins
BL, Du and DL are immunologically related to the equivalent
HeLa proteins. Indeed the Drosophila B and D proteins identified
in this study probably correspond to proteins previously identified
by cross-reactivity with human anti-Sm and anti-snRNP antisera
with reported molecular weights of 18 and 26 000 (19) and 14
and 26 000 (20).
Proteins which are specific to U1, U2 and U5 snRNPs are also
conserved between humans and Drosophila. A counterpart to the
HeLa U5-specific 200K protein which cross reacts with antibodies
raised against the yeast PRP8 protein (29-31) is found in
Drosophila U5-containing particles, as are at least two proteins
of about Mr 100- 120 000 and other proteins potentially
corresponding to the less well characterized 40 and 52K HeLa
U5 proteins.
Drosophila proteins corresponding to the HeLa Ul snRNP
specific 70K and A proteins were recognizable on the basis of
their size and antigenicity, but no protein of equivalent molecular
weight to the HeLa C protein could be detected. An abundant
and potentially U 1-specific protein of Mr 14 500 was, however,
resolved by density centrifugation and may be the Drosophila
counterpart to C (Figures 4A,C).
A protein of similar size to the HeLa U2-specific B' protein
was recognized by an antibody raised against the human protein
(24). This antibody also recognizes a protein of M, 27 000
present in plant nuclear extracts and the gene encoding B' has
recently been cloned from potato and shown to be highly
conserved between the animal and plant kingdoms (43). A
candidate gene coding for either the U2-specific A' or B' proteins
has recently been cloned from Drosophila (44).
As in HeLa extracts, a number of electrophoretically distinct
species of around 70 000 were detected. The most abundant of
these had an apparent molecular weight similar to that of the most
abundant HeLa 70K protein (61-62 000 in this system, Figures
2; 4A). However, the species recognized by monoclonal
antibodies raised against the HeLa 70K protein had an apparent
molecular weight of 56-58 000 (Figure 3B). A further species
of 52-54 000 was also detected (Figure 2) and all three or more
bands, perhaps representing modified or partially degraded
versions of 70K, were recognized by some anti-Sm sera
(Figure 3A). The gene encoding the Drosophila 70K protein has
been cloned and found to encode a protein of predicted Mr
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53 000, the amino-terminal region of which is 68% identical to
the human and Xenopus 70K proteins (45). Whilst there is no
evidence in Drosophila that alternative RNA processing pathways
give rise to 70K variants it is possible that some different forms
of 70K may be generated by variable post translational
modifications as has been reported for the mouse and human 70K
proteins (46).
Until now the biochemical purification of snRNP particles for
their characterization has largely been restricted to rodent and
human cell types. Studies on a disparate range of species,
primarily using autoimmune antibodies, have identified proteins
corresponding to D, E, F and G in most systems (reviewed 3).
This study shows that in Drosophila the conservation of the
proteins involved in the mechanism of splicing extends much
further. The striking degree of similarity between the snRNP
proteins found in Drosophila and humans is perhaps not
unexpected, given the evolutionary constraints on maintaining
an accurate and efficient splicing apparatus.
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